The polymorphism of CLOCK gene 3111T/C C>T is associated with susceptibility of Alzheimer disease in Chinese population. 2013

Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
From the *Key Laboratory of Chronobiology of Health Ministry, Basic and Forensic School, Sichuan University, Chengdu; †Department of Oncology, The Affiliated Hospital of North Sichuan Medical College, Nanchong; and ‡Key Laboratory of Biological Effect of Physical Field and Instrument of Sichuan Provincial Department of Education and §Department of Electronic Engineering, Chengdu University of Information Technology, Chengdu, Sichuan; and ∥Department of Geriatrics, The Third Hospital of Mian Yang, Mian Yang, China.

OBJECTIVE In the present study, it was examined whether polymorphism of circadian locomotor output cycle kaput (CLOCK) gene 3111T/C was associated with susceptibility of Alzheimer disease (AD). METHODS This study was conducted using a case-control method. Genotypes of apolipoprotein E (APOE e4) and CLOCK gene 3111T/C were determined by restriction fragment length polymorphism method and TaqMan assay method, respectively. RESULTS In this study, we gathered 296 unrelated AD patients and 423 control subjects. Both in the whole sample and APOE e4 noncarriers, prevalence of C carriers in CLOCK gene 3111T/C in AD patients was significantly higher than that in control subjects (in the whole sample: χ = 37.615, P < 0.0001; in APOE e4 noncarriers: χ = 46.809, P < 0.0001). However, among APOE e4 carriers, prevalence of C carriers in CLOCK gene 3111T/C between patients and control subjects presents nonsignificant difference (χ = 0.812, P = 0.451). CONCLUSIONS Among APOE e4 noncarriers, C carriers in CLOCK gene 3111T/C were associated with a high susceptibility of AD, but among APOE e4 carriers, the functional polymorphism of CLOCK gene 3111T/C was not associated with the susceptibility of AD.

UI MeSH Term Description Entries
D008297 Male Males
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D044466 Asian People Persons having origins in any of the Asian racial groups of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. Note that OMB category ASIAN is available for United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. Asian Continental Ancestry Group,Asian Person,Asiatic Race,Mongoloid Race,Asian Peoples,Asian Persons,Asiatic Races,Mongoloid Races,People, Asian,Person, Asian,Race, Asiatic,Race, Mongoloid
D053327 Apolipoprotein E4 A major and the second most common isoform of apolipoprotein E. In humans, Apo E4 differs from APOLIPOPROTEIN E3 at only one residue 112 (cysteine is replaced by arginine), and exhibits a lower resistance to denaturation and greater propensity to form folded intermediates. Apo E4 is a risk factor for ALZHEIMER DISEASE and CARDIOVASCULAR DISEASES. Apo E epsilon 4,Apo E-4,Apo E4,ApoE4,Apolipoprotein E-4,Apo E 4,Apolipoprotein E 4

Related Publications

Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
November 2014, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
April 2013, The Journal of international medical research,
Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
August 2017, Bulletin of experimental biology and medicine,
Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
April 2013, Archives of medical research,
Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
January 2010, Chronobiology international,
Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
December 2017, Neuroscience bulletin,
Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
January 2014, PloS one,
Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
December 2015, Genetics and molecular research : GMR,
Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
October 2019, Chronobiology international,
Yun-Kang Yang, and Xiao-Dong Peng, and Yong-Hong Li, and Zheng-Rong Wang, and Huang Chang-quan, and Wang Hui, and Qing-Xiu Liu
January 2016, Frontiers in psychiatry,
Copied contents to your clipboard!